Advanced Medical Solutions Group (LON:AMS) Stock Crosses Above 200 Day Moving Average - What's Next?

Key Points

• Advanced Medical Solutions Group (LON:AMS) shares have surpassed their 200-day moving average, indicating potentially positive trading momentum.
• Analysts have reissued a "buy" rating on AMS, with target prices set at GBX 300 by Berenberg Bank and GBX 275 by Deutsche Bank.
• The company holds a strong financial position with a current ratio of 8.39 and a modest debt-to-equity ratio of 37.01.

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 204.25 ($2.75) and traded as high as GBX 205.50 ($2.77). Advanced Medical Solutions Group shares last traded at GBX 202.50 ($2.73), with a volume of 389,448 shares.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Berenberg Bank reissued a "buy" rating and issued a GBX 300 target price on shares of Advanced Medical Solutions Group in a research report on Tuesday, July 15th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 275 price objective on shares of Advanced Medical Solutions Group in a research report on Wednesday, July 16th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Advanced Medical Solutions Group currently has a consensus rating of "Buy" and an average target price of GBX 287.50.

Advanced Medical Solutions Group Trading Up 0.5%

The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. The business's 50-day moving average is GBX 206.04 and its two-hundred day moving average is GBX 204.25. The firm has a market cap of £439.65 million, a P/E ratio of 39.45, a P/E/G ratio of 5.00 and a beta of 0.74.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.